P. Bonomi

Combined Chemoradiotherapy Regimens of Paclitaxel and Carboplatin for Locally Advanced Non–Small-Cell Lung Cancer: A Randomized Phase II Locally Advanced Multi-Modality Protocol

Chandra P. Belani, Hak Choy, P. Bonomi et al. · Journal of Clinical Oncology · 2005 · 428 citations

Medicine, Oncology, Radiation Oncology +16

What is a clinically meaningful change on the Functional Assessment of Cancer Therapy–Lung (FACT-L) Questionnaire?Results from Eastern Cooperative Oncology Group (ECOG) Study 5592

David Cella, David T. Eton, Diane L. Fairclough et al. · Journal of Clinical Epidemiology · 2002 · 381 citations

Pharmacy, Oncology, Health Assessment +14

Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials

Diane L. Fairclough, Harriet F. Peterson, David Cella et al. · Statistics in Medicine · 1998 · 122 citations

Public Health, Biostatistics, Oncology +12

O-263 Randomized 3-arm phase II study of paclitaxel (T), carboplatin (C), and thoracic radiation (TRT) for patients with stage III non-small cell lung cancer (NSCLC). Report of locally advanced multimodality protocol (LAMP) - ACR 427

P. Bonomi, Walter J. Curran, Hak Choy et al. · Lung Cancer · 2003 · 45 citations

Medicine, Oncology, Radiation Oncology +13

Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group

Patrick M. Forde, P. Bonomi, Alice T. Shaw et al. · Clinical Lung Cancer · 2020 · 16 citations

Medicine, Oncology, Clinical Research Regulation +14